Active Ingredient: SEVABERTINIB
Proprietary Name: HYRNUO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219972
Product Number: 001
Approval Date: Nov 19, 2025
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information